Otosenine

CAS : 16958-29-5

Ref. 3D-RAA95829

Informations sur le produit

• Nom: Otosenine
• Synonymes: Spiro[2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-4,2′-oxirane]-3,8,17-trione, 7-hydroxy-3′,6,7,14-tetramethyl-, (1R,2′S,3′S,6R,7R)-, Othosenine, (1R,2′S,3′S,6R,7R)-7-Hydroxy-3′,6,7,14-tetramethylspiro[2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-4,2′-oxirane]-3,8,17-trione, 4,8-Secosenecionan-8,11,16-trione, 15,20-epoxy-15,20-dihydro-12-hydroxy-4-methyl-, (15α,20S)-

Description

Otosenine is a medicinal compound with potent anticancer properties. It is a protein kinase inhibitor that has been shown to inhibit the growth of cancer cells by inducing apoptosis and blocking the cell cycle. Otosenine is particularly effective against tumors in humans, as it has been found in high concentrations in urine samples from cancer patients. This compound works by binding to specific kinases involved in cancer cell proliferation, preventing their activity and ultimately leading to cancer cell death. Otosenine is an analog of other kinase inhibitors and can be used in combination with other anticancer drugs or inhibitors for greater efficacy. Overall, Otosenine holds great promise as a potential treatment for various types of cancers.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 381.4 g/mol
• Formule: C₁₉H₂₇NO₇
• Degré de pureté: Min. 95%